Teresa Ullberg

Dr. Teresa Ullberg

Lund University, Faculty of Medicine, neurology
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Stroke
Verified
Journal Article
Closed access
TUTeresa Ullberg
Teresa Ullberg
EZElisabet Zia
Elisabet Zia
JPJesper Petersson
Jesper Petersson
BNBo Norrving
Bo Norrving
Background and Purpose—: Large longitudinal studies on stroke outcome are scarce. The aim of this study was to analyze predictors and changes in functional outcome during the first year poststroke. Methods—: Data on patients who were independent in activities of daily living (ADL) and hospitalized for acute stroke in 2008 to 2010 were obtained from the Swedish Stroke Register. Case fatality was assessed by linkage to the Swedish Population Register. ADL was defined by independence or dependence in dressing, toileting, and indoor mobility and assessed at 3 and 12 months. Predictors of ADL dependency were assessed through multivariate analysis. Results—: In total, 64 746 patients were included. Case fatality at 3 months was 13.1% (men 11.6% versus women 14.8%; P <0.0001) and at 12 months 18.2% (men 16.4% versus women 20.3%; P <0,0001). In the 35 064 followed-up survivors, ADL dependency rates at 3 and 12 months were 16.2% (men 15.9% versus women 19.2%; P <0.0001) and 28.3% (men 22.7% versus women 34.9%, P <0.0001), respectively. Factors predicting deterioration to ADL dependency between 3 and 12 months were female sex (relative risk [RR]=1.56; 95% confidence interval [CI], 1.50–1.70), diabetes mellitus (RR=1.50; 95% CI, 1.05–1.60), comatose at admittance (RR=2.34; 95% CI, 1.79–3.05), previous stroke (RR=1.52; 95% CI, 1.43–1.61), hemorrhagic or unspecified stroke (RR=1.14; 95% CI, 1.05–1.25), and atrial fibrillation (RR= 1.11; 95% CI, 1.04–1.17). Conclusions—: Transition from ADL independence to dependence was observed in a high proportion of patients between 3 and 12 months, challenging the common belief that functioning after stroke is stable beyond 3 months. Deterioration occurred more commonly in women, among whom 1/6 converted to dependency.

16 February 2022 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
JWJohan Wassélius
Johan Wassélius
FAFabian Arnberg
Fabian Arnberg
MEMia von Euler
Mia von Euler
PWPer Wester
Per Wester
TUTeresa Ullberg
Teresa Ullberg
This review describes the evolution of endovascular treatment for acute ischemic stroke, current state of the art, and the challenges for the next decade. The rapid development of endovascular thrombectomy (EVT), from the first attempts into standard of care on a global scale, is one of the major achievements in modern medicine. It was possible thanks to the establishment of a scientific framework for patient selection, assessment of stroke severity and outcome, technical development by dedicated physicians and the MedTech industry, including noninvasive imaging for patient selection, and radiological outcome evaluation. A series of randomized controlled trials on EVT in addition to intravenous thrombolytics, with overwhelmingly positive results for anterior circulation stroke within 6 h of onset regardless of patient characteristics with a number needed to treat of less than 3 for any positive shift in outcome, paved the way for a rapid introduction of EVT into clinical practice. Within the “extended” time window of 6–24 h, the effect has been even greater for patients with salvageable brain tissue according to perfusion imaging with a number needed to treat below 2. Even so, EVT is only available for a small portion of stroke patients, and successfully recanalized EVT patients do not always achieve excellent functional outcome. The major challenges in the years to come include rapid prehospital detection of stroke symptoms, adequate clinical and radiological diagnosis of severe ischemic stroke cases, enabling effective recanalization by EVT in dedicated angiosuites, followed by personalized post‐EVT stroke care.

1 February 2016 in Stroke
Verified
Journal Article
Closed access
TUTeresa Ullberg
Teresa Ullberg
EZElisabet Zia
Elisabet Zia
JPJesper Petersson
Jesper Petersson
BNBo Norrving
Bo Norrving
Background and Purpose—: Met care demands are key aspects in poststroke quality of care. This study aimed to identify baseline predictors and 12-month factors that were associated with perceived unmet rehabilitation needs 1 year poststroke. Methods—: Data on patients who were independent in activities of daily living, hospitalized for acute stroke during 2008 to 2010, and followed up 1 year poststroke through a postal questionnaire were obtained from the Swedish stroke register. Patients reporting fulfilled rehabilitation needs were compared with those with unmet needs (Chi square test). Results—: The study included 37 383 patients, 46% female. At 12 months, 8019 (21.5%) patients reported unmet rehabilitation needs. Compared with those with met rehabilitation needs, patients reporting unmet rehabilitation needs were older (75.4 versus 72.4 years; P <0.0001); a higher proportion was activities of daily living–dependent (59% versus 31.9%; P <0.0001) and institutionalized (24.3% versus 11.5%; P <0.0001) at 12 months. Poststroke depression (32.3% versus 24.9%; P <0.0001) and insufficient pain medication were more common in patients with unmet needs (54.5% versus 32.3%; P <0.0001). Baseline predictors of unmet rehabilitation needs at 12 months in an age-adjusted model were severe stroke (odds ratio [OR]=3.04; confidence interval [CI]: 2.39–3.87), prior stroke (OR=1.63; CI: 1.53–1.75), female sex (OR=1.14; CI: 1.07–1.20), diabetes mellitus (OR=1.24; CI: 1.15–1.32), stroke other than ischemic (OR=1.26; CI: 1.20–1.32), and atrial fibrillation (OR=1.19; CI: 1.12–1.27). Conclusions—: Unfulfilled rehabilitation needs 1 year poststroke are common and associated with high age, dependency, pain, and depression. Long-term follow-up systems should, therefore, be comprehensive and address multiple domains of poststroke problems, rather than having a single-domain focus.

1 December 2024 in European Stroke Journal
Verified
Journal Article
Open access
DSDaniel Strbian
Daniel Strbian
Georgios TsivgoulisGeorgios Tsivgoulis
Georgios Tsivgoulis
JOJohanna Ospel
Johanna Ospel
SRSilja Räty
Silja Räty
PCPetra Cimflova
Petra Cimflova
WZWim H. van Zwam
Wim H. van Zwam
The aim of the present European Stroke Organisation (ESO) guideline is to provide evidence-based recommendations on the acute management of patients with basilar artery occlusion (BAO). These guidelines were prepared following the Standard Operational Procedure of the ESO and according to the GRADE methodology. Although BAO accounts for only 1%–2% of all strokes, it has very poor natural outcome. We identified 10 relevant clinical situations and formulated the corresponding Population Intervention Comparator Outcomes (PICO) questions, based on which a systematic literature search and review was performed. The working group consisted of 10 voting members (five representing ESO and five ESMINT) and three non-voting junior members. The certainty of evidence was generally very low. In many PICOs, available data were scarce or lacking, hence, we provided expert consensus statements. First, we compared intravenous thrombolysis (IVT) to no IVT, but specific BAO-related data do not exist. Yet, historically, IVT was standard of care for BAO patients who were also included (albeit in small numbers) in IVT trials. Non-randomised studies of IVT-only cohorts showed high proportion of favourable outcomes. Expert Consensus suggests using IVT up to 24 h unless otherwise contraindicated. We further suggest IVT plus endovascular treatment (EVT) over direct EVT. EVT on top of best medical treatment (BMT) was compared to BMT alone within 6 and 6–24 h from last seen well. In both time windows, we observed a different effect of treatment depending on (a) the region where the patients were treated (Europe vs. Asia), (b) on the proportion of IVT in the BMT arm, and (c) on the initial stroke severity. In case of high proportion of IVT in the BMT group and in patients with NIHSS below 10, EVT plus BMT was not found better than BMT alone. Based on very low certainty of evidence, we suggest EVT + BMT over BMT alone (i.e. based on results of patients with at least 10 NIHSS points and a low proportion of IVT in BMT). For patients with an NIHSS below 10, we found no evidence to recommend EVT over BMT. In fact, BMT was non-significantly better and safer than EVT. Furthermore, we found a stronger treatment effect of EVT + BMT over BMT alone in proximal and middle locations of BAO compared to distal location. While recommendations for patients without extensive early ischaemic changes in the posterior fossa can, in general, follow those of other PICOs, we formulated an Expert Consensus Statement suggesting against reperfusion therapy in those with extensive bilateral and/or brainstem ischaemic changes. Another Expert Consensus suggests reperfusion therapy regardless of collateral scores. Based on limited evidence, we suggest direct aspiration over stent retriever as the first-line strategy of mechanical thrombectomy. As an Expert Consensus, we suggest rescue percutaneous transluminal angioplasty and/or stenting after a failed EVT procedure. Finally, based on very low certainty of evidence, we suggest add-on antithrombotic treatment during EVT or within 24 h after EVT in patients with no concomitant IVT and in whom EVT was complicated (defined as failed or imminent re-occlusion, or need for additional stenting or angioplasty).

22 July 2024 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Open access
PDF file
DSDaniel Strbian
Daniel Strbian
Georgios TsivgoulisGeorgios Tsivgoulis
Georgios Tsivgoulis
JOJohanna Ospel
Johanna Ospel
SRSilja Räty
Silja Räty
PCPetra Cimflova
Petra Cimflova
WZWim H. van Zwam
Wim H. van Zwam
The aim of the present European Stroke Organisation (ESO) guideline is to provide evidence-based recommendations on the acute management of patients with basilar artery occlusion (BAO). These guidelines were prepared following the Standard Operational Procedure of the ESO and according to the GRADE methodology. Although BAO accounts for only 1–2% of all strokes, it has very poor natural outcome. We identified 10 relevant clinical situations and formulated the corresponding Population Intervention Comparator Outcomes (PICO) questions, based on which a systematic literature search and review was performed. The working group consisted of 10 voting members (five representing ESO and five representing the European Society of Minimally Invasive Neurological Therapy (ESMINT)) and three non-voting junior members. The certainty of evidence was generally very low. In many PICOs, available data were scarce or lacking, hence, we provided expert consensus statements. First, we compared intravenous thrombolysis (IVT) to no IVT, but specific BAO-related data do not exist. Yet, historically, IVT was standard of care for BAO patients who were also included (although in small numbers) in IVT trials. Non-randomized studies of IVT-only cohorts showed a high proportion of favorable outcomes. Expert Consensus suggests using IVT up to 24 hours unless otherwise contraindicated. We further suggest IVT plus endovascular treatment (EVT) over direct EVT. EVT on top of best medical treatment (BMT) was compared with BMT alone within 6 and 6–24 hours from last seen well. In both time windows, we observed a different effect of treatment depending on a) the region where the patients were treated (Europe vs Asia), b) on the proportion of IVT in the BMT arm, and c) on the initial stroke severity. In case of high proportion of IVT in the BMT group and in patients with a National Institutes of Health Stroke Scale (NIHSS) score below 10, EVT plus BMT was not found better than BMT alone. Based on very low certainty of evidence, we suggest EVT+BMT over BMT alone (this is based on results of patients with at least 10 NIHSS points and a low proportion of IVT in BMT). For patients with an NIHSS score below 10, we found no evidence to recommend EVT over BMT. In fact, BMT was non-significantly better and safer than EVT. Furthermore, we found a stronger treatment effect of EVT+BMT over BMT alone in proximal and middle locations of BAO compared with distal location. While recommendations for patients without extensive early ischemic changes in the posterior fossa can, in general, follow those of other PICOs, we formulated an Expert Consensus Statement suggesting against reperfusion therapy in those with extensive bilateral and/or brainstem ischemic changes. Another Expert Consensus suggests reperfusion therapy regardless of collateral scores. Based on limited evidence, we suggest direct aspiration over stent retriever as the first-line strategy of mechanical thrombectomy. As an Expert Consensus, we suggest rescue percutaneous transluminal angioplasty and/or stenting after a failed EVT procedure. Finally, based on very low certainty of evidence, we suggest add-on antithrombotic treatment during EVT or within 24 hours after EVT in patients with no concomitant IVT and in whom EVT was complicated (defined as failed or imminent re-occlusion, or need for additional stenting or angioplasty).

1 August 2020 in Acta Neurologica Scandinavica
Verified
Journal Article
Open access
PDF file
SSStefan Sennfält
Stefan Sennfält
MPMats Pihlsgård
Mats Pihlsgård
BNBo Norrving
Bo Norrving
TUTeresa Ullberg
Teresa Ullberg
JPJesper Petersson
Jesper Petersson
Objective This paper aims at examining the clinical characteristics of ischemic stroke patients with different levels of pre‐stroke functional dependency, their long‐term outcome, and determinants of five‐year mortality. Materials and methods We describe demographics, comorbidity, treatment, as well as long‐term mortality, and functional status of 5899 pre‐stroke dependent ischemic stroke patients stratified by dependency level and compared to a concurrent cohort of 14 148 pre‐stroke independent patients. The study was based on 2016 survey data from Riksstroke, the Swedish national stroke register, and patients were followed up at three months, 12 months, and either at three or five years. We used Cox regression for mortality predictor analysis and multiple imputation was performed to minimize bias from loss to follow‐up. Results With increasing level of pre‐stroke dependency, comorbidity burden was higher, drug prescription lower, and prognosis less favorable. At three years, the proportion that had died or deteriorated were 82.6%, 87.5%, and 86.3% in moderate, moderately severe, and severe dependency, respectively. In moderate dependency, prognosis was relatively favorable: three‐month mortality was half of that seen in severe dependency (25.3% versus 49.6%). Differences in overall outcome between groups of varying pre‐stroke functional dependency level were statistically significant (p<0.05) at all follow‐up time points. Conclusions There was great heterogeneity between groups of different level of pre‐stroke dependency; those of moderate dependency had a relatively favorable prognosis. Patients of different pre‐stroke level of dependency needs to be addressed separately and further research is needed characterizing this group and exploring management strategies.